Brussels, 15 May 2019 - The Ordinary and Extraordinary Shareholders' General Meetings of Solvac met on May 14, 2019 at the Square, Brussels Meeting Center, Mont des Arts, 1000 Brussels.
All the resolutions of these Meetings were adopted by the shareholders.
In particular, the Ordinary General Meeting approved the payment of dividend per share at € 5.22 gross for the fiscal year 2018, an increase of 4.0% compared to 2017. During this meeting, the shareholders also approved:
- the re-election of Knight Guy de Selliers de Moranville and Mrs Laure le Hardÿ de Beaulieu as independent Board Members and Knight John Kraft de la Saulx as non-independent Member of the Board of Directors for a period of four years, until in May 2023. Mrs Mélodie de Pimodan was appointed Independent Board Member of the Board of Directors for four years, replacing Aude Thibaut de Maisières who decided not to seek a new term of Board Member,
- the term renewal of Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises, Société Civile sous forme de SCRL, whose headquarters are located at 1930 Zaventem, Gateway Building, Luchthaven Brussel Nationaal 1 J, as External Auditor for the company for a period of three years. The appointment of External Auditor will end at the close of the General Shareholders’ Meeting in May 2022.
The Extraordinary General Meeting approved the changes in the by-laws in Article 10bis relating to the authorized capital and in Article 10ter for acquisition of own shares.
Detailed resolutions, voting results and presentations are available on the Solvac website at https://www.solvac.be/fr/investisseurs/assemblees-generales/
Solvac is a public limited company under Belgian law founded in 1983 and listed on Euronext Brussels under the ISIN code BE0003545531 (SOLV). Its assets consist exclusively of a stake of more than 30% in the capital of Solvay SA. Its shares are exclusively nominative. They may be freely held by natural persons or, subject to the approval of the Board of Directors, by legal persons or assimilated, to the conditions set out in its accreditation policy. At December 31, 2018, its market capitalization was 2.4 billion €.
For additional information, please contact:
Solvac S.A.
Champs Elysées street, 43
B-1050 Brussels
Tel. : +32/2/639 66 30
Fax : +32/2/639 66 31
Mail : Investor.relations@solvac.be
Attachment
